T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$3.46B |
| 2 |
UnitedHealth
UNH
|
+$2.79B |
| 3 |
Salesforce
CRM
|
+$2.38B |
| 4 |
Sherwin-Williams
SHW
|
+$1.41B |
| 5 |
Philip Morris
PM
|
+$1.34B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$4.44B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.97B |
| 3 |
GE Aerospace
GE
|
+$2.3B |
| 4 |
HCA Healthcare
HCA
|
+$2.17B |
| 5 |
American International
AIG
|
+$1.68B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.68% |
| 2 | Healthcare | 19.49% |
| 3 | Consumer Discretionary | 13.07% |
| 4 | Financials | 11.17% |
| 5 | Communication Services | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Bread Financial
BFH
$4.46B
| $881K | ﹤0.01% |
23,784
+852
| +4% | +$43.4K |
|
1952
Nu Skin
NUS
$236M
| $875K | ﹤0.01% |
20,205
+292
| +1% | +$13.4K |
|
1953
John Wiley & Sons Class A
WLY
$2.63B
| $874K | ﹤0.01% |
18,309
+316
| +2% | +$16.1K |
|
|
CLDT
1954
Chatham Lodging
CLDT
$590M
| $873K | ﹤0.01% |
83,571
+391
| +0.5% | +$4.92K |
|
1955
QCR Holdings
QCRH
$1.73B
| $872K | ﹤0.01% |
16,146
+101
| +0.6% | +$5.51K |
|
|
ROIC
1956
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $872K | ﹤0.01% |
55,290
+917
| +2% | +$16.4K |
|
1957
ICF International
ICFI
$1.6B
| $871K | ﹤0.01% |
9,167
+134
| +1% | +$13K |
|
1958
Yelp
YELP
$1.28B
| $868K | ﹤0.01% |
31,263
+212
| +0.7% | +$6.58K |
|
1959
Ezcorp Inc
EZPW
$1.78B
| $867K | ﹤0.01% |
115,395
+18,311
| +19% | +$133K |
|
1960
Vishay Intertechnology
VSH
$5.11B
| $866K | ﹤0.01% |
48,617
+659
| +1% | +$12.5K |
|
1961
Sunstone Hotel Investors
SHO
$2.01B
| $864K | ﹤0.01% |
87,060
-1,906
| -2% | -$21.8K |
|
|
DNB
1962
DELISTED
Dun & Bradstreet
DNB
| $863K | ﹤0.01% |
57,400
+16,678
| +41% | +$269K |
|
1963
TriCo Bancshares
TCBK
$1.84B
| $859K | ﹤0.01% |
18,819
+1,095
| +6% | +$46.1K |
|
1964
Sterling Infrastructure
STRL
$16.8B
| $858K | ﹤0.01% |
39,156
+209
| +0.5% | +$5.02K |
|
1965
Corcept Therapeutics
CORT
$12.1B
| $851K | ﹤0.01% |
35,797
+7,230
| +25% | +$158K |
|
1966
MP Materials
MP
$9.91B
| $850K | ﹤0.01% |
26,486
-2,721
| -9% | -$110K |
|
1967
Sabre
SABR
$831M
| $845K | ﹤0.01% |
144,936
+27,244
| +23% | +$228K |
|
|
UNIT
1968
Uniti Group
UNIT
$2.31B
| $842K | ﹤0.01% |
89,333
+4,972
| +6% | +$57.5K |
|
1969
Domo
DOMO
$184M
| $839K | ﹤0.01% |
30,179
+12,560
| +71% | +$461K |
|
|
OPTU
1970
Optimum Communications Inc
OPTU
$227M
| $824K | ﹤0.01% |
89,065
+19,722
| +28% | +$206K |
|
|
DVAX
1971
DELISTED
Dynavax Technologies
DVAX
| $823K | ﹤0.01% |
65,362
+13,264
| +25% | +$141K |
|
1972
AppFolio
APPF
$6.97B
| $821K | ﹤0.01% |
9,054
+2,861
| +46% | +$288K |
|
1973
BridgeBio Pharma
BBIO
$16.4B
| $819K | ﹤0.01% |
90,197
+23,973
| +36% | +$201K |
|
1974
The GEO Group
GEO
$4.14B
| $819K | ﹤0.01% |
124,136
-10,840
| -8% | -$72.1K |
|
1975
Acco Brands
ACCO
$399M
| $817K | ﹤0.01% |
125,113
+774
| +0.6% | +$5.64K |
|
Similar funds
T. Rowe Price Associates's Q2 2022 Portfolio in Review
As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
- T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
- T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
- T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
- T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
- T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.
Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.